Empo Health Unveils Revolutionary Monitoring System for Diabetic Foot Ulcer Management

Empo Health's Innovation in Diabetic Care



Empo Health, a pioneering healthcare technology company, has recently announced the commercialization of its innovative system designed to manage diabetic foot ulcers (DFUs). Following a successful fundraising round of $7 million led by Story Ventures, the company is set to revolutionize the way diabetic patients monitor their foot health, potentially reducing the number of amputations and the associated costs in healthcare.

Diabetic foot ulcers are a significant concern, particularly for the over 20 million Americans suffering from diabetic neuropathy. Failure to monitor these ulcers can lead to serious complications, including unnecessary amputations, which are often preventable. In fact, DFUs account for a staggering $80 billion in healthcare expenses annually in the United States. Empo Health aims to provide an effective solution to this pressing issue through its innovative at-home monitoring system.

Groundbreaking Technology



The core of Empo Health's solution is a dual system composed of the FDA-listed Empo® Footprint imaging scale and the HIPAA-compliant Empo® Remote Health Link service. This revolutionary approach allows patients with neuropathy, who may have lost sensation in their feet, to conduct regular monitoring from the comfort of their homes.

Using this system is straightforward. Patients simply step onto the scale which generates a high-resolution visual image of their feet. This image is automatically forwarded to healthcare providers, enabling them to quickly identify and address potential issues before they escalate.

Initial pilot studies of this technology showed promising results, with around 50% of patients experiencing early signs of ulcers detected through the system. Anuj Khandelwal, the Co-Founder and CEO of Empo Health, emphasized the company’s mission: “We believe that the patients most in need of health monitoring currently have the most difficult access to it. Our aim is to meet these patients in their own homes and provide clinicians with the necessary tools to significantly diminish diabetic foot amputations.”

Strong Backing



Empo Health's recent funding brings its total capital raised to $15 million, with contributions from several respected venture firms, including VTC Ventures and SeaX Ventures. Investors and partners are enthusiastic about the impact of this innovative healthcare solution. Brian Yormak from Story Ventures expressed confidence in Empo's potential, stating that this technology represents a crucial transformation in how diabetes care can evolve.

Furthermore, Empo’s monitoring system, designed for simplicity, ensures that both patients and healthcare providers can use it effectively with minimal training. Eric Dahlseng, Co-Founder and Chief Product Officer, highlights that the interface is user-friendly, taking just seconds for the entire reading process.

Promising Future



As Empo Health moves forward, the company is not only focused on rolling out its novel solutions but also on solidifying partnerships with healthcare providers to deliver real benefits. The collaboration with Carilion Clinic exemplifies how Empo is forging pathways to integrate its technology into existing healthcare frameworks effectively. James Ramey from VTC Ventures shared their excitement about being part of this transformation in-home healthcare monitoring.

Relentlessly working toward improving patient outcomes, Empo Health’s latest venture illuminates the bright future of tech-driven healthcare solutions. The innovative tools are aimed at equipping both patients and providers with essential resources to tackle the harsh realities of diabetes-related complications, and promises to set a standard in medical technology.

For further details about this launch, the public is encouraged to visit Empo Health’s website and explore the advantages of this pioneering health monitoring system.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.